Skip to main navigation Skip to search Skip to main content

Aberrant expression of Rab1A and its prognostic significance in human Colorectal cancer

  • Z. K. Wang
  • , Z. W. Cheng
  • , S. J. Chen
  • , X. G. Zhu
  • , Y. P. Gu
  • , X. D. Yang
  • , L. Sun
  • , W. T. Liu
  • , Y. J. Zhang
  • , J. F. Yuan
  • , K. J. Tian
  • , Y. Z. Yao
  • , S. B. He*
  • *Corresponding author for this work
  • Soochow University

Research output: Contribution to journal › Journal Article › peer-review

13 Scopus citations

Abstract

OBJECTIVE: Colorectal cancer (CRC) is one of the most common types of cancer worldwide. Emerging evidence has verified that Rab1A plays an oncogenic role in several human malignancies including breast cancer, lung cancer, and hepatocellular carcinomas. However, the clinical significance and prognostic impact of Rab1A in CRC is still unclear. PATIENTS AND METHODS: We initiated our investigation by immunohistochemistry and Western blot analysis to confirm Rab1A expression in CRC tissues. Meanwhile, the correlation of Rab1A expression and clinicopathologic features, as well as outcome in CRC patients, were retrospectively analyzed. RESULTS: In the issue, Rab1A is overex-pressed in CRC tissues compared with matched noncancerous tissues. Meanwhile, high Rab1A expression was significantly associated with the TNM stage, lymph node metastasis, and peritoneal metastasis. In addition, multivariate analyses identified Rab1A expression and TNM stage as independent predictors for CRC patients. Moreover, Kaplan-Meier survival analysis showed that patients with high Rab1A expression had a significantly worse survival time than those with low Rab1A expression, which especially affected the survival in CRC patients with advanced stage. Spearman analysis suggested that there was a positive relationship between Rab1A expression and preoperative serum car-cinoembryonic antigen (CEA) for CRC patients. CONCLUSIONS: These results suggested that Rab1A is an important diagnostic marker for CRC, and Rab1A can be used as a valuable bio-marker for prognosis as well as peritoneal metastasis in CRC patients. Rab1A may prove to be clinically useful for developing a new therapeutic target of CRC treatment.

Original languageEnglish
Pages (from-to)4509-4517
Number of pages9
JournalEuropean Review for Medical and Pharmacological Sciences
Volume22
Issue number14
StatePublished - 2018
Externally publishedYes

Bibliographical note

Publisher Copyright:
2018 © Verduci Editore s.r.l. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Aberrant expression
  • Colorectal cancer
  • Immunohistochemistry
  • Peritoneal metastasis
  • Prognosis
  • Rab1A

Fingerprint

Dive into the research topics of 'Aberrant expression of Rab1A and its prognostic significance in human Colorectal cancer'. Together they form a unique fingerprint.

Cite this